Newsfeeds Archive - Page 8 of 8

1 minute read

Adamis Pharmaceuticals Q2 EPS $(0.06) Misses $(0.03) Estimate

August 10, 4:07 PM

Adamis Pharmaceuticals (NASDAQ:ADMP) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.03) by 100 percent. This is unchanged from the same period last year.

ADMP

4 minute read

Biotech Daily: Cancer Causing Impurities In Merck’s Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon’s Monkeypox Trial

By Vandana Singh

August 10, 11:33 AM

Here's a roundup of top developments in the biotech space over the last 24 hours:

ADMP

11 minute read

Earnings Scheduled For August 10, 2022

By Benzinga Insights

August 10, 5:33 AM

Companies Reporting Before The Bell • Wix.com (NASDAQ:WIX) is estimated to report earnings for its second quarter.

AADI

3 minute read

Recap Of Friday’s Biotech Catalysts – End of The Day Summary

By Ragothaman Srinivasan

July 29, 5:24 PM

The U.S. Food and Drug Administration (FDA) has approved Arcutis Biotherapeutics’ (NASDAQ:ARQT) New Drug Application (NDA) for ZORYVE…

ABBV

2 minute read

Adamis Pharmaceuticals Provides Update On Clinical Study Assessing Tempol For The Treatment Of COVID-19

By Benzinga Newsdesk

July 29, 7:31 AM

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) today provided an update on the Company's ongoing U.S. Phase 2/3 clinical trial to evaluate the safety and efficacy of Tempol as a treatment for COVID-19. The

ADMP

5 minute read

This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday

By Lisa Levin

July 22, 5:04 AM

Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending on January 17, 2023.

3 minute read

Why Is Super Micro Computer Higher By More Than 13%? 42 Stocks Moving In Thursday’s Mid-Day Session

By Lisa Levin

July 21, 12:33 PM

Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares jumped 364.3% to $23.22. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending on January 17, 2023.